Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06529055

Effects of Oral Nicotine and Caffeine Pouches on Anaerobic Performance, Autonomic Function, Cognition, and Behavior

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Southern Mississippi · Academic / Other
Sex
Male
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

The goal of this randomized placebo controlled crossover trial is to determine effects of oral nicotine and caffeine pouches on anaerobic performance, autonomic function, cognition, and behavior in adult non-obese adult male volunteers between ages 21 and 40. Accordingly, the primary aims of the study are to determine the effects of acute oral nicotine pouches, oral caffeine pouches, or both, on measures of * anaerobic performance * cognition * cardiovascular and autonomic function * appetite and food intake. Researchers will compare oral nicotine pouches, oral caffeine pouches, both oral nicotine and caffeine pouches, and a flavor and color matched placebo to see if how they differentially affect measurements of * physical performance, * cognition, * cardiovascular and autonomic function * appetite and food intake. On four separate occasions, participants will be asked to place the oral pouches in their mouth and complete several anerobic cycling, cognitive, and balance tests while blood and salivary biomarkers, subjective appetite ratings, and cardiovascular and autonomic function measurements are collected. After each trial, participants will complete a 24-hr food record.

Conditions

Interventions

TypeNameDescription
OTHEROral Pouch - NicotineIngestion of a randomized oral nicotine pouch
OTHEROral Pouch - CaffeineIngestion of a randomized oral caffeine pouch
OTHEROral Pouch - PlaceboIngestion of a randomized oral placebo pouch

Timeline

Start date
2024-07-30
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-07-31
Last updated
2024-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06529055. Inclusion in this directory is not an endorsement.